-+ 0.00%
-+ 0.00%
-+ 0.00%

Alnylam Pharmaceuticals Price Target Cut to $315.00/Share From $410.00 by Truist Securities

Dow Jones·08/04/2026 15:39:00

登錄查看新聞詳情